Pasithea Therapeutics Corp. (KTTA) Financials
KTTA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 56.4 million | 1.5 million |
| Dec. 31, 2025 | 60.2 million | 5.0 million |
| Sept. 30, 2025 | 13.6 million | 1.4 million |
| June 30, 2025 | 17.0 million | 1.8 million |
KTTA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -4.8 million | 139.2 million |
| Dec. 31, 2025 | -5.4 million | -67.8 million |
| Sept. 30, 2025 | -2.9 million | 209.0 million |
| June 30, 2025 | -3.9 million | 57645 |
KTTA Net Income
No data available :(
KTTA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 50.4 million | - | - |
| Dec. 31, 2025 | 55.2 million | - | - |
| Sept. 30, 2025 | 4.1 million | - | - |
| June 30, 2025 | 7.2 million | - | - |
KTTA Shares Outstanding
KTTA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 2.9 billion | 1.9 billion | - |
| Dec. 31, 2025 | - | 2.7 million | 7.5 million | - |
| Sept. 30, 2025 | 5 | 1.4 million | 1.8 million | - |
| June 30, 2025 | 4 | 2.1 million | 1.7 million | - |
KTTA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 157541 |
| Dec. 31, 2025 | - | 157962 |
| Sept. 30, 2025 | - | 181541 |
| June 30, 2025 | - | 161745 |
KTTA
Price: $0.50
52 week price:
Earnings Per Share: -1.42 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 51500
Market Capitalization: 19.5 million